Some experimental studies on 89Zr production
-
, , , , , and
Abstract
The radionuclide 89Zr (T1/2=78.4ߙh) is particularly attractive for in vivo assessment of biochemical proesses characterized by biological half times in the order of several hours. In the present study we assessed the feasibility of 89Zr production via the 89Y(p,n)89Zr reaction. Irradiation tests were performed using a 16.5ߙMeV GE-PETtrace cyclotron. High purity (>99.9%) yttrium metallic foils (0.15ߙmm) were irradiated in a solid target station developed in our Institution. The literature cross section data of all the nuclear reactions possible in the energy range of interest were carefully studied to optimize the irradiation parameters. The irradiated target was dissolved in 1ߙN HCl and the activity of the sample was measured in a CRC-15 PET dose calibrator, setting different values for the calibration factor. The sample activity was then measured usin g a calibrated HPGe gamma ray detector. A comparison of the activity measurements allowed the evaluation of the calibration factor for the Capintec CRC-15 PET; for a 3ߙml syringe geometry, it was found 739±60. Saturation yields of 89Zr were found to be 1150±110ߙMBq/μA for a single 0.15ߙmm thick disc irradiation (Ep=12.6→11.2ߙMeV) and 2400±220ߙMBq/μA for irradiation of two discs of total thickness 0.3ߙmm (Ep=12.6→9.5MeV). Total produced activities in the range of 200–400ߙMBq (according to target thickness) were repeatedly and safely obtained by 60ߙmin bombardments at 20ߙμA. Analysis of gamma ray spectra of all the samples showed a very high radionuclidic purity (>99.9995%).
© by Oldenbourg Wissenschaftsverlag, Bologna, Germany
Articles in the same Issue
- Preface to WIPR 2010
- Development of novel positron emitters for medical applications: nuclear and radiochemical aspects
- One step purification process for no-carrier-added 64Cu produced using enriched nickel target
- Some experimental studies on 89Zr production
- Paving the way to personalized medicine: production of some theragnostic radionuclides at Brookhaven National Laboratory
- Development of PET molecular targeting agents with gallium-68
- Chemical and biological evaluation of scandium(III)-polyaminopolycarboxylate complexes as potential PET agents and radiopharmaceuticals
- Highly stable acyclic bifunctional chelator for 64Cu PET imaging
Articles in the same Issue
- Preface to WIPR 2010
- Development of novel positron emitters for medical applications: nuclear and radiochemical aspects
- One step purification process for no-carrier-added 64Cu produced using enriched nickel target
- Some experimental studies on 89Zr production
- Paving the way to personalized medicine: production of some theragnostic radionuclides at Brookhaven National Laboratory
- Development of PET molecular targeting agents with gallium-68
- Chemical and biological evaluation of scandium(III)-polyaminopolycarboxylate complexes as potential PET agents and radiopharmaceuticals
- Highly stable acyclic bifunctional chelator for 64Cu PET imaging